Saffron’s role in metabolic disorders
Saffron, Page: 471-483
2020
- 17Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures17
- Readers17
- 17
Book Chapter Description
Metabolic disorders are among the most common causes of terminal conditions, such as cardiovascular disease. Pharmacological studies have confirmed the effectiveness of certain medicinal plants in managing metabolic disorders including obesity, metabolic syndrome, and diabetes. In this chapter, the effects of saffron ( Crocus sativus L.) and its derivatives on obesity and diabetes are summarized based on evaluations from multiple experimental and clinical studies. In obesity, saffron derivatives may directly or indirectly inhibit pathophysiology by decreasing food intake, weight gain, inflammatory processes, oxidative stress, and reversing alterations in adipocytokines levels. In diabetes, saffron derivatives have antihyperglycemic and hypolipidemic properties that are able to prevent or treat complications associated with diabetes such as nephropathy, neuropathy, retinopathy, liver damage, and cardiovascular disorders. The mechanisms involved in the antihyperglycemic property of saffron are discussed in this chapter, as are its protective effects against diabetic complications.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/B9780128186381000320; http://dx.doi.org/10.1016/b978-0-12-818638-1.00032-0; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85143302989&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/B9780128186381000320; https://api.elsevier.com/content/article/PII:B9780128186381000320?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:B9780128186381000320?httpAccept=text/plain; https://dul.usage.elsevier.com/doi/; https://dx.doi.org/10.1016/b978-0-12-818638-1.00032-0
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know